Neurofeedback, following protocols outlined and used by the neuroCare Group, is an effective method of treating ADHD and sleep disorders. neuroCare Group actively partners with several research institutions worldwide, to better understand the effects of neurofeedback in the ADHD population (both in children and adults). See below for further details and quality assurance of the neuroCare approach to delivering evidence-based neurofeedback protocols.
Garcia-Pimenta et al. 2021
Treatment Efficacy and Clinical Effectiveness of EEG Neurofeedback as a Personalized and Multimodal Treatment in ADHD: A Critical Review
The study confirms the effectiveness of Neurofeedback when personalised with a Quantitative EEG assessment, but also demonstrates that results improve when this method is used in combination with parental interventions, psychotherapy, sleep hygiene maintenance as well as nutritional advice.
Sustained effects of neurofeedback in ADHD: a systematic review and meta-analysis
This is a systematic review and meta-analysis which looks at data from more than 500 children with ADHD from 10 randomised controlled trials, comparing the effects of Neurofeedback with ‘active treatments’ (including medication and ‘non-active’ (no treatment) conditions. To critically interpret the data, researchers with different views on Neurofeedback contributed to this study. They concluded that Neurofeedback had long-lasting effects after an average of 6 months, with no ongoing therapy sessions needed after the initial program compared to the group which was still taking medication at follow-up, and at follow-up, the effects of neurofeedback were comparable to the effects of medication.
Neurofeedback of Slow Cortical Potentials in Children with ADHD: A Multicenter Randomized Trial Controlling for Unspecific Effects
This is the largest multi-centre randomised study on SCP Neurofeedback, in 150 children with ADHD. The study confirms the specific efficacy of SCP neurofeedback on the core symptoms of ADHD compared to a semi-active control group. This demonstrates the feasibility and, above all, the efficacy of SCP neurofeedback in children with ADHD, controlling for specific and unspecific effects.
The Effects o QEEG-Informed Neurofeedback in ADHD: An Open-Label Pilot Study
This paper demonstrates the results of the ‘individualized’ neurofeedback approach – also called QEEG informed neurofeedback – which is employed within neuroCare Clinics worldwide. This manuscript also summarises how personalisation of neurofeedback treatment, both within this study and in an earlier study by an independent group, potentially doubles clinical treatment effects.
Would you like to find out more about our Neurofeedback programs?
Submit your enquiry today and one of our experienced staff will be in touch to explain the next steps.
We integrate leading research, digital therapeutics, physical devices, clinics, and professional education to offer the most comprehensive mental health solutions to patients, therapists and the research community.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.